DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 45 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $116,194,000 | -46.1% | 5,763,585 | -0.2% | 0.00% | -50.0% |
Q2 2021 | $215,543,000 | +37.8% | 5,775,534 | -5.6% | 0.01% | +20.0% |
Q1 2021 | $156,417,000 | +17.7% | 6,117,166 | +1.4% | 0.01% | +25.0% |
Q4 2020 | $132,944,000 | +27.4% | 6,034,729 | +4.1% | 0.00% | 0.0% |
Q3 2020 | $104,323,000 | -30.8% | 5,798,854 | -2.3% | 0.00% | -33.3% |
Q2 2020 | $150,731,000 | +62.2% | 5,934,280 | +17.3% | 0.01% | +20.0% |
Q1 2020 | $92,926,000 | -4.8% | 5,058,547 | +14.1% | 0.01% | +25.0% |
Q4 2019 | $97,661,000 | +55.7% | 4,433,090 | +1.5% | 0.00% | +33.3% |
Q3 2019 | $62,704,000 | -6.8% | 4,366,493 | +2.2% | 0.00% | 0.0% |
Q2 2019 | $67,285,000 | +7.7% | 4,272,060 | +0.2% | 0.00% | 0.0% |
Q1 2019 | $62,462,000 | +34.9% | 4,263,619 | -1.6% | 0.00% | +50.0% |
Q4 2018 | $46,300,000 | +2.3% | 4,331,228 | +46.0% | 0.00% | 0.0% |
Q3 2018 | $45,277,000 | +41.7% | 2,967,073 | +13.8% | 0.00% | +100.0% |
Q2 2018 | $31,946,000 | +1104.6% | 2,607,895 | +839.8% | 0.00% | – |
Q1 2018 | $2,652,000 | +150.2% | 277,493 | +136.5% | 0.00% | – |
Q4 2017 | $1,060,000 | +62.6% | 117,321 | +3.5% | 0.00% | – |
Q3 2017 | $652,000 | +79.1% | 113,396 | -1.5% | 0.00% | – |
Q2 2017 | $364,000 | -17.8% | 115,065 | -11.8% | 0.00% | – |
Q1 2017 | $443,000 | +6228.6% | 130,453 | +5679.9% | 0.00% | – |
Q4 2016 | $7,000 | -69.6% | 2,257 | -41.7% | 0.00% | – |
Q3 2016 | $23,000 | +91.7% | 3,874 | 0.0% | 0.00% | – |
Q2 2016 | $12,000 | +1100.0% | 3,874 | +1693.5% | 0.00% | – |
Q1 2016 | $1,000 | -99.7% | 216 | -98.3% | 0.00% | -100.0% |
Q1 2014 | $356,000 | – | 12,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |